Literature DB >> 19675326

New, but not improved? Incorporating comparative-effectiveness information into FDA labeling.

Randall S Stafford1, Todd H Wagner, Philip W Lavori.   

Abstract

Mesh:

Year:  2009        PMID: 19675326     DOI: 10.1056/NEJMp0906490

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

Review 1.  Substituting placebo for established, effective therapy: why not?

Authors:  Stan Shapiro; Dean Fergusson; Kathleen Cranley Glass
Journal:  CMAJ       Date:  2010-06-14       Impact factor: 8.262

2.  Open versus laparoscopic versus robotic gastrectomy for cancer: need for comparative-effectiveness quality.

Authors:  G Glantzounis; D Ziogas; G Baltogiannis
Journal:  Surg Endosc       Date:  2010-06       Impact factor: 4.584

3.  Robotic versus laparoscopic surgery for rectal cancer and cost-effectiveness analysis.

Authors:  Christof Hottenrott
Journal:  Surg Endosc       Date:  2011-12       Impact factor: 4.584

4.  Laparoscopic low vs. high anterior resection for rectal cancer.

Authors:  E Hanisch; D Ziogas
Journal:  Surg Endosc       Date:  2010-09       Impact factor: 4.584

5.  US FDA Modernization Act, section 114: uses, opportunities and implications for comparative effectiveness research.

Authors:  Peter J Neumann; Pei-Jung Lin; Tom E Hughes
Journal:  Pharmacoeconomics       Date:  2011-08       Impact factor: 4.981

6.  Comparison of Drug Utilization Patterns in Observational Data: Antiepileptic Drugs in Pediatric Patients.

Authors:  Florence T Bourgeois; Karen L Olson; Annapurna Poduri; Kenneth D Mandl
Journal:  Paediatr Drugs       Date:  2015-10       Impact factor: 3.022

7.  Enhancing prescription drug innovation and adoption.

Authors:  G Caleb Alexander; Alec B O'Connor; Randall S Stafford
Journal:  Ann Intern Med       Date:  2011-06-21       Impact factor: 25.391

Review 8.  An early indicator of drug success: Top Journal Selectivity Index.

Authors:  Igor Kissin
Journal:  Drug Des Devel Ther       Date:  2013-02-13       Impact factor: 4.162

9.  Comparative effectiveness research: an empirical study of trials registered in ClinicalTrials.gov.

Authors:  Florence T Bourgeois; Srinivas Murthy; Kenneth D Mandl
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

10.  Designing concept maps for a precise and objective description of pharmaceutical innovations.

Authors:  Maia Iordatii; Alain Venot; Catherine Duclos
Journal:  BMC Med Inform Decis Mak       Date:  2013-01-18       Impact factor: 2.796

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.